BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

715 related articles for article (PubMed ID: 8675088)

  • 21. Impaired Intestinal Permeability Contributes to Ongoing Bowel Symptoms in Patients With Inflammatory Bowel Disease and Mucosal Healing.
    Chang J; Leong RW; Wasinger VC; Ip M; Yang M; Phan TG
    Gastroenterology; 2017 Sep; 153(3):723-731.e1. PubMed ID: 28601482
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gut microbiota in mucosa and feces of newly diagnosed, treatment-naïve adult inflammatory bowel disease and irritable bowel syndrome patients.
    Čipčić Paljetak H; Barešić A; Panek M; Perić M; Matijašić M; Lojkić I; Barišić A; Vranešić Bender D; Ljubas Kelečić D; Brinar M; Kalauz M; Miličević M; Grgić D; Turk N; Karas I; Čuković-Čavka S; Krznarić Ž; Verbanac D
    Gut Microbes; 2022; 14(1):2083419. PubMed ID: 35695669
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of levels of antibodies from patients with inflammatory bowel disease with extracellular proteins of food and probiotic bacteria.
    Hevia A; López P; Suárez A; Jacquot C; Urdaci MC; Margolles A; Sánchez B
    Biomed Res Int; 2014; 2014():351204. PubMed ID: 24991549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
    Stecher B
    Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence, significance and predictive value of antiphospholipid antibodies in Crohn's disease.
    Sipeki N; Davida L; Palyu E; Altorjay I; Harsfalvi J; Szalmas PA; Szabo Z; Veres G; Shums Z; Norman GL; Lakatos PL; Papp M
    World J Gastroenterol; 2015 Jun; 21(22):6952-64. PubMed ID: 26078573
    [TBL] [Abstract][Full Text] [Related]  

  • 26.
    Loganes C; Valencic E; Pin A; Marini E; Martelossi S; Naviglio S; De Leo L; Not T; Monasta L; Tommasini A; Marcuzzi A
    World J Gastroenterol; 2016 Nov; 22(44):9734-9743. PubMed ID: 27956797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease.
    D'Haens G; Ferrante M; Vermeire S; Baert F; Noman M; Moortgat L; Geens P; Iwens D; Aerden I; Van Assche G; Van Olmen G; Rutgeerts P
    Inflamm Bowel Dis; 2012 Dec; 18(12):2218-24. PubMed ID: 22344983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibody responses to gut bacteria in ankylosing spondylitis, rheumatoid arthritis, Crohn's disease and ulcerative colitis.
    Tiwana H; Wilson C; Walmsley RS; Wakefield AJ; Smith MS; Cox NL; Hudson MJ; Ebringer A
    Rheumatol Int; 1997; 17(1):11-6. PubMed ID: 9194209
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gut lavage IgG and interleukin 1 receptor antagonist:interleukin 1 beta ratio as markers of intestinal inflammation in children with inflammatory bowel disease.
    Troncone R; Caputo N; Campanozzi A; Cucciardi M; Esposito V; Russo R; De Vizia B; Greco L; Cucchiara S
    Gut; 1997 Jul; 41(1):60-5. PubMed ID: 9274473
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systemic and mucosal antibodies to Klebsiella in patients with ankylosing spondylitis and Crohn's disease.
    O'Mahony S; Anderson N; Nuki G; Ferguson A
    Ann Rheum Dis; 1992 Dec; 51(12):1296-300. PubMed ID: 1485810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Higher titers of anti-Saccharomyces cerevisiae antibodies IgA and IgG are associated with more aggressive phenotypes in Romanian patients with Crohn's disease.
    Gologan S; Iacob R; Preda C; Vadan R; Cotruta B; Catuneanu AM; Iacob S; Constantinescu I; Gheorghe L; Iobagiu S; Gheorghe C; Diculescu M
    J Gastrointestin Liver Dis; 2012 Mar; 21(1):39-44. PubMed ID: 22457858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specificities of the fecal microbiota in inflammatory bowel disease.
    Sokol H; Seksik P; Rigottier-Gois L; Lay C; Lepage P; Podglajen I; Marteau P; Doré J
    Inflamm Bowel Dis; 2006 Feb; 12(2):106-11. PubMed ID: 16432374
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro immunoglobulin secretion by normal human gastrointestinal mucosal tissues, and alterations in patients with inflammatory bowel disease.
    Danis VA; Harries AD; Heatley RV
    Clin Exp Immunol; 1984 Apr; 56(1):159-66. PubMed ID: 6713728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autoimmunity in ulcerative colitis (UC): a predominant colonic mucosal B cell response against human tropomyosin isoform 5.
    Onuma EK; Amenta PS; Ramaswamy K; Lin JJ; Das KM
    Clin Exp Immunol; 2000 Sep; 121(3):466-71. PubMed ID: 10971512
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunoglobulins and IgG subclasses in patients with inflammatory bowel disease.
    Gouni-Berthold I; Baumeister B; Berthold HK; Schmidt C
    Hepatogastroenterology; 1999; 46(27):1720-3. PubMed ID: 10430330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distinct patterns of IgG and IgA against food and microbial antigens in serum and feces of patients with inflammatory bowel diseases.
    Frehn L; Jansen A; Bennek E; Mandic AD; Temizel I; Tischendorf S; Verdier J; Tacke F; Streetz K; Trautwein C; Sellge G
    PLoS One; 2014; 9(9):e106750. PubMed ID: 25215528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Profiles of Lamina Propria T Helper Cell Subsets Discriminate Between Ulcerative Colitis and Crohn's Disease.
    Li J; Ueno A; Fort Gasia M; Luider J; Wang T; Hirota C; Jijon HB; Deane M; Tom M; Chan R; Barkema HW; Beck PL; Kaplan GG; Panaccione R; Qian J; Iacucci M; Gui X; Ghosh S
    Inflamm Bowel Dis; 2016 Aug; 22(8):1779-92. PubMed ID: 27243594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel anti-glycan antibodies related to inflammatory bowel disease diagnosis and phenotype.
    Seow CH; Stempak JM; Xu W; Lan H; Griffiths AM; Greenberg GR; Steinhart AH; Dotan N; Silverberg MS
    Am J Gastroenterol; 2009 Jun; 104(6):1426-34. PubMed ID: 19491856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selected bacterial antibodies in Crohn's disease and ulcerative colitis.
    Auer IO; Röder A; Wensinck F; van de Merwe JP; Schmidt H
    Scand J Gastroenterol; 1983 Mar; 18(2):217-23. PubMed ID: 6673050
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease.
    Swidsinski A; Weber J; Loening-Baucke V; Hale LP; Lochs H
    J Clin Microbiol; 2005 Jul; 43(7):3380-9. PubMed ID: 16000463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.